125 related articles for article (PubMed ID: 36524484)
21. Baicalin attenuates diet induced nonalcoholic steatohepatitis by inhibiting inflammation and oxidative stress via suppressing JNK signaling pathways.
Zhong X; Liu H
Biomed Pharmacother; 2018 Feb; 98():111-117. PubMed ID: 29247950
[TBL] [Abstract][Full Text] [Related]
22. [Nicotine alleviates the liver inflammation of non-alcoholic steatohepatitis induced by high-fat and high-fructose in mice].
Chen XM; Li FQ; Yan S; Wu XC; Tang CL
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):777-782. PubMed ID: 27752155
[TBL] [Abstract][Full Text] [Related]
23. Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1α-mediated JNK and NF-κB pathways in ApoE-/- mice.
Luo Y; Dong X; Yu Y; Sun G; Sun X
J Ethnopharmacol; 2015 Apr; 163():241-50. PubMed ID: 25655997
[TBL] [Abstract][Full Text] [Related]
24. Pentoxifylline alleviates high-fat diet-induced non-alcoholic steatohepatitis and early atherosclerosis in rats by inhibiting AGE and RAGE expression.
Wu J; Zhao MY; Zheng H; Zhang H; Jiang Y
Acta Pharmacol Sin; 2010 Oct; 31(10):1367-75. PubMed ID: 20835270
[TBL] [Abstract][Full Text] [Related]
25. Adelmidrol protects against non-alcoholic steatohepatitis in mice.
Nageeb MM; Khatab MI; Abdel-Sameea AA; Teleb NA
Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):777-784. PubMed ID: 31853615
[TBL] [Abstract][Full Text] [Related]
26. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
Zaitone S; Hassan N; El-Orabi N; El-Awady el-S
Eur J Pharmacol; 2011 Jul; 662(1-3):70-7. PubMed ID: 21549113
[TBL] [Abstract][Full Text] [Related]
27. Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats.
Zhao JS; Zhu FS; Liu S; Yang CQ; Chen XM
Chin Med J (Engl); 2012 Jul; 125(13):2316-21. PubMed ID: 22882855
[TBL] [Abstract][Full Text] [Related]
28. Derlin-1 promotes diet-induced non-alcoholic fatty liver disease via increasing RIPK3-mediated necroptosis.
Wang T; Wang D; Kuang G; Gong X; Zhang L; Wan J; Li K
Free Radic Biol Med; 2024 May; 217():29-47. PubMed ID: 38522486
[TBL] [Abstract][Full Text] [Related]
29. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
[TBL] [Abstract][Full Text] [Related]
30. [Effect of nicotinic acetylcholine receptor α7 subunit gene on liver inflammatory reaction in mice with nonalcoholic steatohepatitis and related mechanisms].
Li FQ; Wu XC; Xu LN; Chen XM; Lu S; Tang CL
Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):767-771. PubMed ID: 27938563
[No Abstract] [Full Text] [Related]
31. The Ameliorative Effects of Saikosaponin in Thioacetamide-Induced Liver Injury and Non-Alcoholic Fatty Liver Disease in Mice.
Chang GR; Lin WL; Lin TC; Liao HJ; Lu YW
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768813
[TBL] [Abstract][Full Text] [Related]
32. The ménage à trois of autophagy, lipid droplets and liver disease.
Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
[TBL] [Abstract][Full Text] [Related]
33. Hepatoprotective and antioxidant activities of extracts from Salvia-Nelumbinis naturalis against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet in mice.
Liu Y; Song H; Wang L; Xu H; Shu X; Zhang L; Li Y; Li D; Ji G
J Transl Med; 2014 Nov; 12():315. PubMed ID: 25406833
[TBL] [Abstract][Full Text] [Related]
34. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats.
Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W
Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797
[TBL] [Abstract][Full Text] [Related]
35. Ethyl pyruvate supplemented in drinking water ameliorates experimental nonalcoholic steatohepatitis.
Sun X; Zhu S; Dong X; Strand-Amundsen RJ; Tonnessen TI; Yang R
Biomed Pharmacother; 2021 May; 137():111392. PubMed ID: 33761609
[TBL] [Abstract][Full Text] [Related]
36. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
Serviddio G; Bellanti F; Vendemiale G
Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
[TBL] [Abstract][Full Text] [Related]
37. Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease.
Christensen CU; Glavind E; Thomsen KL; Kim YO; Heebøll S; Schuppan D; Hamilton-Dutoit S; Würtz Heegaard C; Grønbæk H
PLoS One; 2018; 13(3):e0192728. PubMed ID: 29522534
[TBL] [Abstract][Full Text] [Related]
38. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
39. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
Abd El-Haleim EA; Bahgat AK; Saleh S
Eur J Pharmacol; 2016 Feb; 773():59-70. PubMed ID: 26825546
[TBL] [Abstract][Full Text] [Related]
40. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.
Zhang N; Wang Y; Zhang J; Liu B; Li G; Xin S; Xu K
Mol Med Rep; 2019 Aug; 20(2):1363-1372. PubMed ID: 31173200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
